Has Pfizer's Bid for Warner Killed the Only Strategic M&A Alternative?
Executive SummaryThe last resistance to the wave of pharmaceutical megadeals has fallen. Pfizer Inc.'s hostile bid for Warner-Lambert Co., interrupting Warner's friendly merger with American Home Products Corp. effectively calls into question the only viable alternative to M&A; co-promotions.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.